CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvag152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Corinna Schulte und 39 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, Pauwelsstraße 30, Aachen 52074, Germany. Hauptthemen laut MEDLINE: Oxidative Stress, Myocardial Infarction, Energy Metabolism, Renal Insufficiency, Chronic. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Research Foundation, European Union, Marie Skłodowska-Curie.
Abstract (Originalsprache)
Aims
Patients with chronic kidney disease (CKD) display a reduced survival following myocardial infarction (MI). As the underlying mechanisms remain unclear, we examined the impact of CKD on cardiac remodeling and function post-MI using a mouse model of adenine-induced CKD. Methods and results After MI, CKD mice showed a stronger cardiac dysfunction compared to non-CKD controls. While immunohistochemical and immunofluorescence analyses did not reveal changes in cardiomyocyte apoptosis, infarction size, or myofibroblast content, CKD mice exhibited an increased number of circulating myeloid cells post-infarction and more neutrophil infiltration in the heart. Combining RNAseq, untargeted kinome profiling, western blotting, and mass spectrometry revealed that post-MI, CKD enhanced cardiac oxidative stress and the acute stress complex S100A8/A9 in circulation and the heart, and enforced cardiac MAP-kinase p38 activation and NR4A1 phosphorylation as pathways underlying cardiomyocyte dysfunction. S100A8/A9 also exerted an acute detrimental impact on calcium flux and sarcomere shortening in cardiomyocytes ex vivo. Increased myeloid cell-derived S100A8/A9 expression was confirmed in the infarcted human heart by single-nucleus RNAseq, and CKD patients had higher post-infarction S100A8/A9 levels compared to patients without kidney dysfunction. Furthermore, integrating metabolomics, RNAseq, and mitochondrial analysis uncovered a disturbed cardiac metabolism with impaired glycolysis, a reduced glycerol-3-phosphate-shuttle, and a reduced Coenzyme A-bioavailability in CKD vs. non-CKD mice post-MI. These alterations were associated with poorer cardiac performance post-MI, without intrinsic defects in mitochondrial function observed.
Conclusion
Our study reveals innate immune activation, inflammation, oxidative stress, and metabolic alterations indicative of reduced glycolytic entry and CoA bioavailability along with aggravated cardiac dysfunction post-MI in CKD compared to non-CKD conditions, independent of infarct size, and with poorer cardiac performance in CKD associated with the cardiac metabolic alterations. Combined, this could contribute to the worsened outcome of CKD patients post-MI and reveals cardiac metabolism in CKD as an interesting translational research target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, Pauwelsstraße 30, Aachen 52074, Germany.
- Department of Internal Medicine I, Cardiology, Uniklinik RWTH Aachen, Aachen, Germany.
- Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Würzburg, Germany.
- Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
- Central Laboratory, Tianjin Medical University General Hospital, Tianjin, China.
- Department of Medicine II, Uniklinik RWTH Aachen, Aachen, Germany.
ORCID-Profile: Sina Hourtz, Michael Kohlhaas, Martin Reugels, Dickson W L Wong, Martin Berger, Berkan Kurt, Evangelos Giannitsis, Hugo A Katus, Katharina Marx-Schütt, Rafael Kramann, Florian Kahles, Peter Boor, Claudia Goettsch, Sikander Hayat, Joachim Jankowski, Christoph Maack, Yvonne Döring, Nikolaus Marx, Heidi Noels
Förderung
- German Research Foundation
- European Union
- Marie Skłodowska-Curie
- Else Kröner-Fresenius-Stiftung
- RWTH Aachen University
- German Centre for Cardiovascular Research
- Alexander von Humboldt Foundation
- Corona Foundation
Zitieren
APA
Schulte, C., Wollenhaupt, J., Hourtz, S., Harlacher, E., Moellmann, J., Cruz Junho, C. V., Kohlhaas, M., Jankowski, V., Jin, H., Reugels, M., Maryam, S., Hausmann, F., Wong, D. W. L., van der Vorst, E. P. C., Berger, M., Vondenhoff, S., Kurt, B., Ghesquière, B., Mueller, C., …, & Noels, H. (2026). CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag152
Vancouver
Schulte C, Wollenhaupt J, Hourtz S, Harlacher E, Moellmann J, Cruz Junho CV, et al. CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag152
BibTeX
@article{Schulte2026,
author = {Schulte, Corinna and Wollenhaupt, Julia and Hourtz, Sina and Harlacher, Eva and Moellmann, Julia and Cruz Junho, Carolina Victoria and Kohlhaas, Michael and Jankowski, Vera and Jin, Han and Reugels, Martin and Maryam, Sidrah and Hausmann, Franca and Wong, Dickson W L and van der Vorst, Emiel P C and Berger, Martin and Vondenhoff, Sonja and Kurt, Berkan and Ghesquière, Bart and Mueller, Constanze and Schulze-Späte, Ulrike and Schmitt-Kopplin, Philippe and Biessen, Erik A L and Prates-Roma, Leticia and Biener, Moritz and Giannitsis, Evangelos and Katus, Hugo A and Schunk, Stefan and Fliser, Danilo and Marx-Schütt, Katharina and Lehrke, Michael and Kramann, Rafael and Kahles, Florian and Boor, Peter and Goettsch, Claudia and Hayat, Sikander and Jankowski, Joachim and Maack, Christoph and Döring, Yvonne and Marx, Nikolaus and Noels, Heidi},
title = {CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag152}
}
EUVIMED